Haemacure gets Hemaseel trial approval:
This article was originally published in Clinica
Executive Summary
Haemacure has been given approval by the FDA to begin a Phase II trial of its Hemaseel biological tissue glue. The adhesive is a liquid derived from human plasma which is a capable of stopping bleeding. The company, based in Montreal, Canada, intends to demonstrate the efficacy of its glue to control post-surgical bleeding and will begin the trial in the US later this month. US company ClinTrials Research is managing the study.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.